Skip to content

Opening book details…

About this Medicine article

Pharmacokinetics, Pharmacodynamics, and Tolerability of Aleglitazar in Patients With Type 2 Diabetes: Results From a Randomized, Placebo-Controlled Clinical Study by Sanwald-Ducray, P; Liogier D'ardhuy, X; Jamois, C; Banken, L is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Sanwald-Ducray, P; Liogier D'ardhuy, X; Jamois, C; Banken, L
Publisher
Nature Publishing Group; Wiley (Blackwell Publishing); Wiley-Blackwell; Wiley; Springer Science and Business Media LLC; Research Square (ISSN 0009-9236)
Published
2010
Field
Medicine (Health Sciences)

More by Sanwald-Ducray, P; Liogier D'ardhuy, X; Jamois, C; Banken, L

Browse all works by Sanwald-Ducray, P; Liogier D'ardhuy, X; Jamois, C; Banken, L